Facebook Inc (NASDAQ:FB) chief executive Mark Zuckerberg sets himself a “personal challenge” every year, from wearing a tie every day in 2009 and learning to speak Mandarin in 2010 to only eating meat in 2011 if he killed the animal himself, The Guardian reports. Facebook Inc (NASDAQ:FB) in last trading activity moved down -1.51% to close at $78.02. Company weekly performance is -3.21% while its quarterly performance stands at 1.92%. Facebook Inc (NASDAQ:FB) is -5.05% away from its 52 week high.
News has it that Gilead Sciences, Inc. (NASDAQ:GILD) is looking forward to sealing an acquisition deal with Arrowhead Research Corp (NASDQ:ARWR). The company bought a small cap of the latter’s stock, and now it wants to acquire the whole company. According to the news, the healthcare giant wants to acquire Arrowhead for its hepatitis B drugs. On last trading day Gilead Sciences Inc. (NASDAQ:GILD) moved down -1.07% to close at $94.26. Its volatility for the week is 2.92% while volatility for the month is 3.33%. GILD’s sales growth for past 5 years was 16.00% and its EPS growth for past 5 years was 11.90%. Gilead Sciences Inc. (NASDAQ:GILD) monthly performance is -6.26%.
JPMorgan Chase & Co. started coverage on shares of Macquarie Infrastructure Company LLC (NYSE:MIC) in a research report released on Tuesday morning. The firm issued an overweight rating on the stock. Macquarie Infrastructure Company LLC (NYSE:MIC) has 5.20% insider ownership while its institutional ownership stands at 85.20%. In last trading activity company’s stock closed at $71.09.
The Medicines Company, a global biopharmaceutical company focussed on hospital care, and Pharmaceuticals, Inc. (NASDAQ:SCLN), an US based, China focussed specialty pharmaceutical company, announced the establishment of a strategic partnership for two cardiovascular products in China. The partnership includes an agreement granting SciClone a licence and the exclusive rights in China to promote two products of The Medicines Company. On Wednesday shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) closed at $8.76. Company’s sales growth for last 5 years was 18.60% and EPS growth for next 5 years is recorded as 14.10%.
Stamps.com Inc (NASDAQ:STMP) Insider Seth Weisberg sold 1,900 shares of the stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $50.00, for a total value of $95,000.00. Following the transaction, the insider now directly owns 11,086 shares of the company’s stock, valued at approximately $554,300. On last trading day Stamps.com Inc. (NASDAQ:STMP) moved up 0.29% to close at $47.99. Its volatility for the week is 2.93% while volatility for the month is 3.32%. STMP’s sales growth for past 5 years was 8.50% and its EPS growth for past 5 years was 38.60%. Stamps.com Inc. (NASDAQ:STMP) monthly performance is 2.98%.